Irinotecan Accord 100 mg/5 ml Concentrato per soluzione per Infusione

Country: Շվեյցարիա

language: իտալերեն

source: Swissmedic (Swiss Agency for Therapeutic Products)

active_ingredient:

irinotecani hydrochloridum trihydricum

MAH:

Accord Healthcare AG

ATC_code:

L01CE02

INN:

irinotecani hydrochloridum trihydricum

pharmaceutical_form:

Concentrato per soluzione per Infusione

composition:

irinotecani hydrochloridum trihydricum 100 mg, acidum lacticum, sorbitolum 225 mg, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 5 ml corresp. natrium max. 0.4 mg.

class:

A

therapeutic_group:

Synthetika

therapeutic_area:

Farmaco

authorization_status:

zugelassen

authorization_date:

2018-09-24